Home > Insider Trading > Filing (0001062993-21-012213)

Filing Details

Accession Number:: 0001062993-21-012213
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-12-03 19:02:59
Reporting Period:: 2021-12-01

Accepted Time:: 2021-12-03 19:02:59
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1177648	Enanta Pharmaceuticals Inc	ENTA	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1646976	Nathalie Adda	C/O Enanta Pharmaceuticals, Inc. 500 Arsenal Street Watertown MA 02472	Sr. Vp & Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2021-12-01	842	$87.68	32,902	No	4	F	Direct
Common Stock	Acquisiton	2021-12-01	8,750	$43.46	41,652	No	4	M	Direct
Common Stock	Acquisiton	2021-12-01	4,773	$48.52	46,425	No	4	M	Direct
Common Stock	Disposition	2021-12-01	1,587	$84.81	44,838	No	4	S	Direct
Common Stock	Disposition	2021-12-01	5,736	$85.49	39,102	No	4	S	Direct
Common Stock	Disposition	2021-12-01	2,700	$86.45	36,402	No	4	S	Direct
Common Stock	Disposition	2021-12-01	1,500	$87.60	34,902	No	4	S	Direct
Common Stock	Disposition	2021-12-01	900	$88.31	34,002	No	4	S	Direct
Common Stock	Disposition	2021-12-01	899	$89.33	33,103	No	4	S	Direct
Common Stock	Disposition	2021-12-01	201	$90.17	32,902	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	F	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2021-12-01	8,750	$0.00	8,750	$43.46
Common Stock	Stock Option (Right to Buy)	Disposition	2021-12-01	4,773	$0.00	4,773	$48.52

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
46,020		2025-06-29	No	4	M	Direct
9,180		2027-11-17	No	4	M	Direct

Footnotes

Represents the number of shares of ENTA common stock forfeited by the reporting person to cover withholding taxes due as a result of settlement of a portion of the restricted stock unit award granted on November 20, 2020.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in May 2021.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $84.43 to $84.98, inclusive.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $85.04 to $85.98, inclusive.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $86.03 to $86.91, inclusive.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $87.23 to $87.92, inclusive.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $88.01 to $88.90, inclusive.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $89.02 to $89.88, inclusive.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $90.00 to $90.25, inclusive.
100% of the shares subject to the option are fully vested and exercisable.